Back to Search
KENNETH ATAGA, MD
MD
Hematology & Oncology Physician
NPI: 1306886825IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
9700849(NC)57803(TN)
CMS Specialties
PrimaryHEMATOLOGY/ONCOLOGY
Education
OTHER
Class of 1990
Research & Publications (20)
Senicapoc (ICA-17043): a potential therapy for the prevention and treatment of hemolysis-associated complications in sickle cell anemia.
PMID 19236269·Expert Opin Investig Drugs·2009
6-review
Hypercoagulability in sickle cell disease and beta-thalassemia.
PMID 18991650·Curr Mol Med·2008
6-review
Fibronectin bridges monocytes and reticulocytes via integrin alpha4beta1.
PMID 18422998·Br J Haematol·2008
8-other
Efficacy and safety of the Gardos channel blocker, senicapoc (ICA-17043), in patients with sickle cell anemia.
PMID 18192510·Blood·2008
2-rct
Identification of genetic polymorphisms associated with risk for pulmonary hypertension in sickle cell disease.
PMID 18187665·Blood·2008
4-observational
Coagulation activation and inflammation in sickle cell disease-associated pulmonary hypertension.
PMID 18166781·Haematologica·2008
8-other
Hypercoagulability in sickle cell disease: new approaches to an old problem.
PMID 18024615·Hematology Am Soc Hematol Educ Program·2007
6-review
Phase I study of eptifibatide in patients with sickle cell anaemia.
PMID 17916103·Br J Haematol·2007
3-trial
Beta-thalassaemia and sickle cell anaemia as paradigms of hypercoagulability.
PMID 17854302·Br J Haematol·2007
6-review
Genetic polymorphisms associated with priapism in sickle cell disease.
PMID 17408468·Br J Haematol·2007
8-other
Dose-escalation study of ICA-17043 in patients with sickle cell disease.
PMID 17064199·Pharmacotherapy·2006
3-trial
Pulmonary hypertension in patients with sickle cell disease: a longitudinal study.
PMID 16803576·Br J Haematol·2006
8-other
Biologically active CD40 ligand is elevated in sickle cell anemia: potential role for platelet-mediated inflammation.
PMID 16601237·Arterioscler Thromb Vasc Biol·2006
8-other
The influence of renal function on hydroxyurea pharmacokinetics in adults with sickle cell disease.
PMID 15778424·J Clin Pharmacol·2005
3-trial
Role of Rap1 in promoting sickle red blood cell adhesion to laminin via BCAM/LU.
PMID 15613546·Blood·2005
8-other
Mechanism of CD47-induced alpha4beta1 integrin activation and adhesion in sickle reticulocytes.
PMID 15292185·J Biol Chem·2004
8-other
Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment.
PMID 12672732·JAMA·2003
3-trial
Novel epinephrine and cyclic AMP-mediated activation of BCAM/Lu-dependent sickle (SS) RBC adhesion.
PMID 12506027·Blood·2003
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1325 EASTMORELAND AVE STE 101
MEMPHIS, TN 38104 - Phone
- (901) 516-8785
Quick Facts
- NPI
- 1306886825
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 36
- Publications
- 20
Are you this provider?
Claim Your Profile